Mechanistic insights into daidzin from Glycine max against breast cancer via network pharmacology and multi-level molecular modeling
Lan Thi Vu, Luong Trong Vu, Lien Thi Kim Vu, Hang Thi Thuy Pho, Quan Huu Nguyen, Lan Thi Ngoc Nguyen, Yen Thi Hai Nguyen, Hung Duc Nguyen · 2026
Read Mechanistic insights into daidzin from Glycine max against breast cancer via network pharmacology and multi-level molecular modeling by Lan Thi Vu, Luong Trong Vu, Lien Thi Kim Vu, Hang Thi Thuy Pho, Quan Huu Nguyen, Lan Thi Ngoc Nguyen, Yen Thi Hai Nguyen, Hung Duc Nguyen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355672.txt.
Description
Lan Thi Vu and co-authors mapped how daidzin, a soy compound, might act against breast cancer using network pharmacology and molecular modelling. Soy isoflavones attract cancer interest, but this compound's routes were poorly defined. Their 2026 in silico study predicted the compound's protein targets and intersected them with breast cancer genes.
Ninety-seven shared targets emerged. Ten hub proteins sat at the network's centre, spanning inflammation, hormone signalling, and tissue-cutting enzymes. Docking placed daidzin snugly against all ten hubs, most strongly against a matrix-cutting enzyme tied to tumour spread. Its grip there beat the reference compound used for comparison. Vu and colleagues present the map as a prioritised hypothesis set for bench testing.
Catalog record
| CREATOR | Lan Thi Vu, Luong Trong Vu, Lien Thi Kim Vu, Hang Thi Thuy Pho, Quan Huu Nguyen, Lan Thi Ngoc Nguyen, Yen Thi Hai Nguyen, Hung Duc Nguyen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70031 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |